Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: C4 Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
C4 Therapeutics Inc. June 24, 202683.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 19, 2026 | Insmed Incorporated | Grant or award | +6,139 | — | — |
| Mar 2, 2023 | Atara Biotherapeutics Inc. | Open-market sale | −6,871 | $3.63 | $24,942 |
| Feb 8, 2023 | C4 Therapeutics Inc. | Open-market purchase | +5,667 | $5.60 | $31,735 |
| Feb 7, 2023 | Atara Biotherapeutics Inc. | Open-market sale | −2,485 | $5.46 | $13,568 |
Questions about Utpal Koppikar
What boards is Utpal Koppikar on?
Utpal Koppikar sits on the boards of C4 Therapeutics Inc. and Insmed Incorporated.
How long has Utpal Koppikar served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.